Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 24 | 2001 | 185 | 2.080 |
Why?
|
Magnetic Resonance Imaging | 31 | 2001 | 2148 | 1.150 |
Why?
|
Angiography | 13 | 2000 | 151 | 0.780 |
Why?
|
Tomography, X-Ray Computed | 22 | 2009 | 1593 | 0.770 |
Why?
|
Femoral Artery | 7 | 2001 | 110 | 0.720 |
Why?
|
Embolization, Therapeutic | 9 | 2019 | 314 | 0.680 |
Why?
|
Aortic Aneurysm | 8 | 2005 | 87 | 0.620 |
Why?
|
Heart Defects, Congenital | 7 | 1999 | 101 | 0.610 |
Why?
|
Contrast Media | 12 | 2003 | 422 | 0.600 |
Why?
|
Angioplasty, Balloon | 7 | 1999 | 58 | 0.590 |
Why?
|
Coronary Disease | 8 | 1998 | 246 | 0.570 |
Why?
|
Stents | 8 | 1999 | 487 | 0.570 |
Why?
|
Angiography, Digital Subtraction | 11 | 2003 | 133 | 0.560 |
Why?
|
Coronary Angiography | 14 | 2002 | 200 | 0.540 |
Why?
|
Punctures | 7 | 2001 | 64 | 0.540 |
Why?
|
Catheterization | 7 | 2001 | 111 | 0.530 |
Why?
|
Humans | 149 | 2019 | 62955 | 0.520 |
Why?
|
Arteriovenous Malformations | 7 | 1997 | 43 | 0.510 |
Why?
|
Ultrasonography | 18 | 2000 | 479 | 0.490 |
Why?
|
Pulmonary Veins | 7 | 1998 | 38 | 0.470 |
Why?
|
Aorta, Thoracic | 9 | 1999 | 82 | 0.470 |
Why?
|
Thrombolytic Therapy | 4 | 2004 | 190 | 0.460 |
Why?
|
Catheterization, Central Venous | 5 | 1996 | 87 | 0.440 |
Why?
|
Coronary Vessel Anomalies | 4 | 2002 | 21 | 0.440 |
Why?
|
Arterial Occlusive Diseases | 4 | 2000 | 74 | 0.430 |
Why?
|
Urokinase-Type Plasminogen Activator | 3 | 2004 | 11 | 0.430 |
Why?
|
Radiography, Interventional | 6 | 1998 | 74 | 0.410 |
Why?
|
Aortic Aneurysm, Thoracic | 6 | 2001 | 111 | 0.400 |
Why?
|
Plasminogen Activators | 2 | 2004 | 10 | 0.390 |
Why?
|
Popliteal Artery | 3 | 1999 | 27 | 0.390 |
Why?
|
Catheterization, Peripheral | 5 | 1999 | 53 | 0.380 |
Why?
|
Heart Diseases | 6 | 1999 | 216 | 0.350 |
Why?
|
Vascular Diseases | 5 | 1997 | 81 | 0.350 |
Why?
|
Peripheral Vascular Diseases | 4 | 2004 | 49 | 0.340 |
Why?
|
Cardiac Catheterization | 6 | 1996 | 281 | 0.340 |
Why?
|
Diagnostic Imaging | 4 | 2000 | 263 | 0.340 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2000 | 667 | 0.320 |
Why?
|
Echocardiography | 7 | 2000 | 500 | 0.320 |
Why?
|
Pulmonary Artery | 6 | 1999 | 93 | 0.300 |
Why?
|
Angiocardiography | 3 | 1994 | 6 | 0.300 |
Why?
|
Chemoembolization, Therapeutic | 4 | 2003 | 11 | 0.290 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2001 | 244 | 0.280 |
Why?
|
Ischemia | 7 | 2000 | 204 | 0.270 |
Why?
|
Foreign-Body Migration | 2 | 1997 | 21 | 0.260 |
Why?
|
Heart Injuries | 2 | 1998 | 19 | 0.260 |
Why?
|
Hepatic Artery | 3 | 2003 | 20 | 0.250 |
Why?
|
Heart Atria | 3 | 2002 | 138 | 0.250 |
Why?
|
Aortic Diseases | 5 | 1997 | 74 | 0.250 |
Why?
|
Catheters, Indwelling | 3 | 2003 | 69 | 0.240 |
Why?
|
Foreign Bodies | 3 | 1995 | 47 | 0.230 |
Why?
|
Radiography, Thoracic | 4 | 1995 | 116 | 0.230 |
Why?
|
Thorax | 2 | 1995 | 34 | 0.230 |
Why?
|
Middle Aged | 43 | 2019 | 17422 | 0.220 |
Why?
|
Carotid Artery Diseases | 4 | 1994 | 66 | 0.220 |
Why?
|
Sensitivity and Specificity | 9 | 2000 | 1141 | 0.210 |
Why?
|
United States Food and Drug Administration | 2 | 2004 | 91 | 0.210 |
Why?
|
Diabetic Angiopathies | 2 | 2000 | 25 | 0.210 |
Why?
|
Radiography | 11 | 1999 | 539 | 0.210 |
Why?
|
Male | 53 | 2019 | 29602 | 0.210 |
Why?
|
Liver Neoplasms | 3 | 2003 | 296 | 0.200 |
Why?
|
Hematoma | 2 | 2001 | 78 | 0.200 |
Why?
|
Vascular Fistula | 1 | 2002 | 8 | 0.200 |
Why?
|
Radiology, Interventional | 2 | 2009 | 32 | 0.200 |
Why?
|
Radiographic Image Enhancement | 5 | 1999 | 98 | 0.190 |
Why?
|
Angioplasty, Laser | 2 | 1991 | 2 | 0.190 |
Why?
|
Echocardiography, Transesophageal | 3 | 1998 | 109 | 0.190 |
Why?
|
Cardiovascular Diseases | 5 | 2000 | 832 | 0.180 |
Why?
|
Pulmonary Embolism | 2 | 2004 | 171 | 0.180 |
Why?
|
Portal Vein | 6 | 2001 | 38 | 0.170 |
Why?
|
Leg | 5 | 2000 | 87 | 0.170 |
Why?
|
Phlebography | 7 | 1995 | 44 | 0.170 |
Why?
|
Myocardium | 4 | 1994 | 275 | 0.170 |
Why?
|
Vascular Patency | 6 | 2003 | 139 | 0.170 |
Why?
|
Drug Approval | 1 | 2000 | 26 | 0.170 |
Why?
|
Cardiomyopathies | 3 | 1999 | 123 | 0.170 |
Why?
|
Penis | 3 | 1988 | 32 | 0.170 |
Why?
|
Heart | 4 | 1994 | 282 | 0.160 |
Why?
|
Iliac Artery | 3 | 1999 | 49 | 0.160 |
Why?
|
Polyvinyls | 1 | 2019 | 20 | 0.160 |
Why?
|
Aorta, Abdominal | 5 | 1995 | 59 | 0.160 |
Why?
|
Urinary Fistula | 1 | 2019 | 17 | 0.160 |
Why?
|
Neuroendocrine Tumors | 1 | 1999 | 22 | 0.160 |
Why?
|
Lidocaine | 1 | 1999 | 33 | 0.160 |
Why?
|
Thrombosis | 5 | 1996 | 199 | 0.160 |
Why?
|
Carotid Stenosis | 2 | 1998 | 105 | 0.160 |
Why?
|
Electrodes, Implanted | 2 | 1997 | 37 | 0.160 |
Why?
|
Ureter | 1 | 2019 | 34 | 0.160 |
Why?
|
Vena Cava, Inferior | 2 | 1998 | 32 | 0.160 |
Why?
|
Aortic Valve Stenosis | 2 | 1994 | 188 | 0.160 |
Why?
|
Adult | 29 | 2001 | 16688 | 0.160 |
Why?
|
Urinary Incontinence | 1 | 2019 | 45 | 0.160 |
Why?
|
Duodenum | 1 | 1999 | 42 | 0.150 |
Why?
|
Anesthetics, Local | 1 | 1999 | 71 | 0.150 |
Why?
|
Appointments and Schedules | 1 | 1999 | 59 | 0.150 |
Why?
|
Stomach | 1 | 1999 | 86 | 0.150 |
Why?
|
Veins | 7 | 1997 | 64 | 0.150 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1999 | 79 | 0.150 |
Why?
|
Wounds, Penetrating | 1 | 1998 | 26 | 0.140 |
Why?
|
Myocardial Ischemia | 2 | 1999 | 118 | 0.140 |
Why?
|
Practice Guidelines as Topic | 2 | 2001 | 728 | 0.140 |
Why?
|
Aged | 27 | 2019 | 14296 | 0.140 |
Why?
|
Kidney Diseases | 2 | 1992 | 174 | 0.140 |
Why?
|
Calcinosis | 1 | 1998 | 83 | 0.140 |
Why?
|
Equipment Design | 6 | 1996 | 348 | 0.140 |
Why?
|
Palliative Care | 1 | 2019 | 226 | 0.140 |
Why?
|
Heart Ventricles | 2 | 1996 | 263 | 0.140 |
Why?
|
Metals | 1 | 1997 | 65 | 0.130 |
Why?
|
Female | 38 | 2019 | 32610 | 0.130 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1996 | 5 | 0.130 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 1996 | 26 | 0.130 |
Why?
|
Coronary Artery Bypass | 2 | 2002 | 297 | 0.130 |
Why?
|
Pericarditis, Constrictive | 1 | 1996 | 3 | 0.130 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 1996 | 8 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 1996 | 46 | 0.130 |
Why?
|
Pain | 1 | 1999 | 407 | 0.130 |
Why?
|
Azygos Vein | 1 | 1995 | 4 | 0.120 |
Why?
|
Heart Valve Prosthesis | 1 | 1997 | 111 | 0.120 |
Why?
|
Computers | 1 | 1995 | 49 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Cine | 4 | 2002 | 108 | 0.120 |
Why?
|
Fistula | 2 | 1995 | 13 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2019 | 6564 | 0.120 |
Why?
|
Renal Artery Obstruction | 4 | 1995 | 19 | 0.120 |
Why?
|
Hemochromatosis | 1 | 1994 | 6 | 0.120 |
Why?
|
Ebstein Anomaly | 1 | 1994 | 2 | 0.120 |
Why?
|
Cerebrovascular Disorders | 3 | 1990 | 81 | 0.110 |
Why?
|
Erectile Dysfunction | 3 | 1988 | 26 | 0.110 |
Why?
|
Technology Assessment, Biomedical | 1 | 1994 | 12 | 0.110 |
Why?
|
Castleman Disease | 1 | 1994 | 4 | 0.110 |
Why?
|
Mediastinal Diseases | 1 | 1994 | 15 | 0.110 |
Why?
|
Heart Neoplasms | 1 | 1994 | 36 | 0.110 |
Why?
|
Gallium Radioisotopes | 1 | 1993 | 14 | 0.110 |
Why?
|
Heart Septal Defects | 1 | 1993 | 2 | 0.110 |
Why?
|
Pericarditis | 1 | 1993 | 9 | 0.110 |
Why?
|
Kidney | 5 | 2000 | 444 | 0.110 |
Why?
|
Subclavian Artery | 1 | 1993 | 26 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2019 | 5608 | 0.110 |
Why?
|
Abdomen | 1 | 1993 | 92 | 0.110 |
Why?
|
Mammary Arteries | 2 | 1993 | 10 | 0.100 |
Why?
|
Vasodilator Agents | 3 | 2000 | 68 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 1997 | 265 | 0.100 |
Why?
|
Coronary Thrombosis | 1 | 1993 | 21 | 0.100 |
Why?
|
Aneurysm | 1 | 1993 | 60 | 0.100 |
Why?
|
Melanoma | 1 | 1996 | 332 | 0.100 |
Why?
|
Pancreatic Diseases | 1 | 1992 | 39 | 0.100 |
Why?
|
Pericardial Effusion | 1 | 1992 | 21 | 0.100 |
Why?
|
Software | 1 | 1995 | 384 | 0.100 |
Why?
|
Diatrizoate | 2 | 1989 | 4 | 0.100 |
Why?
|
Dipyridamole | 3 | 1996 | 17 | 0.090 |
Why?
|
Injections, Intra-Arterial | 3 | 2003 | 21 | 0.090 |
Why?
|
Equipment Failure | 3 | 1996 | 65 | 0.090 |
Why?
|
Brachial Artery | 1 | 1991 | 29 | 0.090 |
Why?
|
Electrocardiography | 5 | 2000 | 554 | 0.090 |
Why?
|
Catheter Ablation | 1 | 1993 | 153 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 1991 | 54 | 0.090 |
Why?
|
Mesenteric Arteries | 2 | 1987 | 10 | 0.090 |
Why?
|
Aged, 80 and over | 12 | 2019 | 5422 | 0.090 |
Why?
|
Urinary Bladder | 2 | 1987 | 44 | 0.090 |
Why?
|
Brain Abscess | 1 | 1990 | 7 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 1996 | 965 | 0.080 |
Why?
|
Lung | 2 | 1997 | 942 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 1990 | 49 | 0.080 |
Why?
|
Body Burden | 1 | 2009 | 12 | 0.080 |
Why?
|
Thoracic Arteries | 1 | 1989 | 3 | 0.080 |
Why?
|
Radiometry | 1 | 2009 | 36 | 0.080 |
Why?
|
Radiation Protection | 1 | 2009 | 27 | 0.080 |
Why?
|
Urinary Catheterization | 2 | 1987 | 20 | 0.080 |
Why?
|
Aortitis | 3 | 1993 | 5 | 0.080 |
Why?
|
Carotid Arteries | 1 | 1989 | 61 | 0.080 |
Why?
|
Aminopyrine | 1 | 1988 | 1 | 0.080 |
Why?
|
Dipyrone | 1 | 1988 | 1 | 0.080 |
Why?
|
Butylscopolammonium Bromide | 1 | 1988 | 2 | 0.080 |
Why?
|
Parasympatholytics | 1 | 1988 | 7 | 0.080 |
Why?
|
Ventricular Fibrillation | 1 | 1989 | 105 | 0.070 |
Why?
|
Pulmonary Emphysema | 1 | 1989 | 103 | 0.070 |
Why?
|
Scopolamine Derivatives | 1 | 1988 | 14 | 0.070 |
Why?
|
Urinary Bladder Diseases | 1 | 1987 | 9 | 0.070 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 1998 | 50 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 447 | 0.070 |
Why?
|
General Surgery | 1 | 1989 | 207 | 0.070 |
Why?
|
United States | 4 | 2004 | 7757 | 0.060 |
Why?
|
Diagnostic Errors | 2 | 2000 | 98 | 0.060 |
Why?
|
Hypertension, Renovascular | 1 | 1986 | 6 | 0.060 |
Why?
|
Deglutition | 1 | 2006 | 19 | 0.060 |
Why?
|
Femoral Vein | 2 | 1996 | 19 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 1993 | 911 | 0.060 |
Why?
|
Intestines | 1 | 1987 | 166 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2006 | 43 | 0.060 |
Why?
|
Radiology | 1 | 1989 | 248 | 0.060 |
Why?
|
Prospective Studies | 7 | 1999 | 3266 | 0.060 |
Why?
|
Length of Stay | 2 | 1999 | 806 | 0.060 |
Why?
|
Drainage | 1 | 1985 | 154 | 0.060 |
Why?
|
Infant, Newborn | 3 | 1995 | 1349 | 0.060 |
Why?
|
Motion Pictures | 2 | 1994 | 11 | 0.060 |
Why?
|
Radionuclide Imaging | 2 | 1994 | 122 | 0.060 |
Why?
|
Cardiac Output | 2 | 1996 | 28 | 0.050 |
Why?
|
Drug and Narcotic Control | 1 | 2004 | 28 | 0.050 |
Why?
|
Evaluation Studies as Topic | 3 | 1993 | 104 | 0.050 |
Why?
|
Carotid Artery, Internal | 2 | 1997 | 68 | 0.050 |
Why?
|
Aortography | 2 | 1993 | 59 | 0.050 |
Why?
|
Behcet Syndrome | 2 | 2001 | 4 | 0.050 |
Why?
|
Tissue Plasminogen Activator | 1 | 2004 | 126 | 0.050 |
Why?
|
Pentetic Acid | 3 | 1996 | 33 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 1985 | 315 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2005 | 258 | 0.050 |
Why?
|
Fluoroscopy | 2 | 2006 | 64 | 0.050 |
Why?
|
Organometallic Compounds | 3 | 1996 | 65 | 0.050 |
Why?
|
Ligaments | 1 | 2001 | 9 | 0.050 |
Why?
|
Retroperitoneal Space | 1 | 2001 | 22 | 0.050 |
Why?
|
Liver Abscess | 1 | 2001 | 18 | 0.050 |
Why?
|
Observer Variation | 3 | 2002 | 211 | 0.050 |
Why?
|
Contraindications | 2 | 1999 | 50 | 0.040 |
Why?
|
Escherichia coli Infections | 1 | 2001 | 87 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 1999 | 275 | 0.040 |
Why?
|
Heart Valve Diseases | 2 | 1999 | 93 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 1985 | 378 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2001 | 114 | 0.040 |
Why?
|
Time Factors | 3 | 2019 | 3754 | 0.040 |
Why?
|
Drug Industry | 1 | 2000 | 39 | 0.040 |
Why?
|
Gadolinium DTPA | 3 | 2000 | 87 | 0.040 |
Why?
|
Postoperative Complications | 3 | 1997 | 1292 | 0.040 |
Why?
|
Myocarditis | 1 | 2000 | 66 | 0.040 |
Why?
|
Posture | 1 | 2000 | 127 | 0.040 |
Why?
|
Postoperative Period | 1 | 1999 | 138 | 0.040 |
Why?
|
Pericardium | 1 | 1999 | 35 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2000 | 169 | 0.040 |
Why?
|
Artifacts | 1 | 2000 | 128 | 0.040 |
Why?
|
Foot | 1 | 1999 | 42 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 1999 | 200 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 1998 | 26 | 0.040 |
Why?
|
Subclavian Vein | 2 | 1995 | 12 | 0.040 |
Why?
|
Vena Cava, Superior | 2 | 1995 | 9 | 0.040 |
Why?
|
Lung Diseases | 2 | 1997 | 176 | 0.040 |
Why?
|
Pain Measurement | 1 | 1999 | 343 | 0.040 |
Why?
|
Brachiocephalic Trunk | 1 | 1997 | 16 | 0.040 |
Why?
|
Hospital Costs | 1 | 1998 | 126 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 1998 | 91 | 0.030 |
Why?
|
Hemosiderosis | 1 | 1997 | 2 | 0.030 |
Why?
|
Cyanosis | 1 | 1997 | 7 | 0.030 |
Why?
|
Graft Occlusion, Vascular | 1 | 1997 | 62 | 0.030 |
Why?
|
Survival Rate | 1 | 1999 | 845 | 0.030 |
Why?
|
Cerebellar Diseases | 1 | 1997 | 9 | 0.030 |
Why?
|
Ossification, Heterotopic | 1 | 1997 | 13 | 0.030 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 1997 | 20 | 0.030 |
Why?
|
Child | 4 | 1991 | 4484 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1997 | 28 | 0.030 |
Why?
|
Aortic Coarctation | 1 | 1996 | 6 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1996 | 10 | 0.030 |
Why?
|
Aneurysm, False | 2 | 1994 | 50 | 0.030 |
Why?
|
Headache | 1 | 1997 | 58 | 0.030 |
Why?
|
Heart Valves | 1 | 1996 | 25 | 0.030 |
Why?
|
Neoplasms | 2 | 1999 | 1350 | 0.030 |
Why?
|
Rotation | 1 | 1996 | 23 | 0.030 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 1996 | 3 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 1997 | 83 | 0.030 |
Why?
|
Safety | 1 | 1997 | 145 | 0.030 |
Why?
|
Ascites | 1 | 1996 | 21 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1996 | 47 | 0.030 |
Why?
|
Portal System | 1 | 1996 | 3 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 1997 | 95 | 0.030 |
Why?
|
Guideline Adherence | 1 | 1998 | 306 | 0.030 |
Why?
|
Mitral Valve | 1 | 1997 | 118 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 1999 | 338 | 0.030 |
Why?
|
Superior Vena Cava Syndrome | 1 | 1995 | 7 | 0.030 |
Why?
|
Surveys and Questionnaires | 1 | 2004 | 2655 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2000 | 2157 | 0.030 |
Why?
|
False Negative Reactions | 1 | 1995 | 41 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 1999 | 340 | 0.030 |
Why?
|
Surface Properties | 1 | 1996 | 278 | 0.030 |
Why?
|
False Positive Reactions | 1 | 1995 | 78 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 2 | 1997 | 222 | 0.030 |
Why?
|
Collateral Circulation | 1 | 1995 | 25 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2000 | 1644 | 0.030 |
Why?
|
Cineangiography | 1 | 1994 | 2 | 0.030 |
Why?
|
Thallium Radioisotopes | 1 | 1994 | 9 | 0.030 |
Why?
|
User-Computer Interface | 1 | 1995 | 124 | 0.030 |
Why?
|
Treatment Failure | 1 | 1995 | 199 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1994 | 33 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 1996 | 72 | 0.030 |
Why?
|
Image Enhancement | 1 | 1996 | 191 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 1995 | 1082 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2000 | 1545 | 0.030 |
Why?
|
Regional Blood Flow | 3 | 1996 | 112 | 0.030 |
Why?
|
Fetal Heart | 1 | 1994 | 5 | 0.030 |
Why?
|
Intraoperative Period | 1 | 1994 | 34 | 0.030 |
Why?
|
Carotid Artery, Common | 1 | 1994 | 31 | 0.030 |
Why?
|
Esophagus | 1 | 1994 | 50 | 0.030 |
Why?
|
Bronchial Arteries | 1 | 1993 | 3 | 0.030 |
Why?
|
Fever of Unknown Origin | 1 | 1993 | 4 | 0.030 |
Why?
|
Hemoptysis | 1 | 1993 | 8 | 0.030 |
Why?
|
Vascular Resistance | 2 | 1991 | 48 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 1994 | 39 | 0.030 |
Why?
|
Thoracotomy | 1 | 1994 | 46 | 0.030 |
Why?
|
Blood Vessels | 1 | 1994 | 62 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 1994 | 134 | 0.030 |
Why?
|
Heart Septum | 1 | 1993 | 57 | 0.030 |
Why?
|
Ultrasonics | 1 | 1993 | 16 | 0.030 |
Why?
|
Drug Combinations | 2 | 1996 | 165 | 0.030 |
Why?
|
Legionellosis | 1 | 1993 | 2 | 0.030 |
Why?
|
Exercise Test | 1 | 1994 | 251 | 0.030 |
Why?
|
Pregnancy | 2 | 1994 | 2327 | 0.030 |
Why?
|
Pericardial Window Techniques | 1 | 1992 | 1 | 0.030 |
Why?
|
Coronary Vessels | 1 | 1993 | 119 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 1993 | 75 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 1992 | 30 | 0.020 |
Why?
|
Iron | 1 | 1993 | 146 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 1993 | 487 | 0.020 |
Why?
|
Bacteremia | 1 | 1993 | 94 | 0.020 |
Why?
|
Pancreas | 1 | 1992 | 150 | 0.020 |
Why?
|
Acute Disease | 2 | 1992 | 671 | 0.020 |
Why?
|
Subtraction Technique | 2 | 1988 | 23 | 0.020 |
Why?
|
Metoclopramide | 1 | 1991 | 12 | 0.020 |
Why?
|
Urination | 2 | 1987 | 13 | 0.020 |
Why?
|
Coronary Aneurysm | 1 | 1990 | 7 | 0.020 |
Why?
|
Blood Pressure | 2 | 1991 | 515 | 0.020 |
Why?
|
England | 1 | 1990 | 29 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 1990 | 50 | 0.020 |
Why?
|
Emphysema | 1 | 1990 | 39 | 0.020 |
Why?
|
Pneumothorax | 1 | 1990 | 50 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1990 | 102 | 0.020 |
Why?
|
Iopamidol | 1 | 1989 | 13 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 1990 | 57 | 0.020 |
Why?
|
Adolescent | 2 | 1990 | 6202 | 0.020 |
Why?
|
Risk Factors | 1 | 2000 | 5315 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 1994 | 735 | 0.020 |
Why?
|
Single-Blind Method | 2 | 2000 | 144 | 0.020 |
Why?
|
North America | 1 | 2009 | 111 | 0.020 |
Why?
|
Angina, Unstable | 1 | 1989 | 58 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1992 | 731 | 0.020 |
Why?
|
Renal Circulation | 1 | 1987 | 13 | 0.020 |
Why?
|
Research Design | 1 | 1991 | 573 | 0.020 |
Why?
|
Technetium | 1 | 1987 | 68 | 0.020 |
Why?
|
Hospitals | 1 | 1990 | 393 | 0.020 |
Why?
|
Prostatic Hyperplasia | 1 | 1987 | 20 | 0.020 |
Why?
|
Viscera | 1 | 1986 | 10 | 0.020 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 1987 | 14 | 0.020 |
Why?
|
Celiac Artery | 1 | 1987 | 14 | 0.020 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 1986 | 24 | 0.020 |
Why?
|
Enalapril | 1 | 1986 | 2 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2003 | 2449 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 1985 | 31 | 0.020 |
Why?
|
Prognosis | 1 | 1990 | 1734 | 0.020 |
Why?
|
Video Recording | 1 | 2006 | 133 | 0.010 |
Why?
|
Constriction, Pathologic | 2 | 1997 | 121 | 0.010 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 1984 | 5 | 0.010 |
Why?
|
Salicylates | 1 | 1984 | 9 | 0.010 |
Why?
|
Acidosis | 1 | 1984 | 26 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1985 | 294 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2006 | 106 | 0.010 |
Why?
|
Infant | 1 | 1989 | 1626 | 0.010 |
Why?
|
Iodized Oil | 1 | 2003 | 2 | 0.010 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2003 | 3 | 0.010 |
Why?
|
Polyvinyl Alcohol | 1 | 2003 | 10 | 0.010 |
Why?
|
Maryland | 1 | 2003 | 35 | 0.010 |
Why?
|
Cohort Studies | 1 | 1989 | 2552 | 0.010 |
Why?
|
Mitomycin | 1 | 2003 | 26 | 0.010 |
Why?
|
Liver | 2 | 1999 | 846 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2003 | 36 | 0.010 |
Why?
|
Hemostatics | 1 | 2003 | 26 | 0.010 |
Why?
|
Doxorubicin | 1 | 2003 | 99 | 0.010 |
Why?
|
Cisplatin | 1 | 2003 | 140 | 0.010 |
Why?
|
Mesenteric Artery, Superior | 1 | 2001 | 14 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 864 | 0.010 |
Why?
|
Life Tables | 1 | 1999 | 23 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 662 | 0.010 |
Why?
|
Hepatic Veins | 1 | 1996 | 13 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1997 | 96 | 0.010 |
Why?
|
Kidney Medulla | 1 | 1996 | 7 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1996 | 10 | 0.010 |
Why?
|
Patient Selection | 1 | 1999 | 483 | 0.010 |
Why?
|
Meglumine | 1 | 1996 | 20 | 0.010 |
Why?
|
Esophageal and Gastric Varices | 1 | 1996 | 11 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 1999 | 308 | 0.010 |
Why?
|
Reoperation | 1 | 1996 | 290 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1994 | 27 | 0.010 |
Why?
|
Liver Diseases | 1 | 1996 | 148 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 1996 | 171 | 0.010 |
Why?
|
Recurrence | 1 | 1996 | 638 | 0.010 |
Why?
|
Renal Artery | 1 | 1994 | 34 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1996 | 215 | 0.010 |
Why?
|
Chronic Disease | 1 | 1997 | 751 | 0.010 |
Why?
|
Brachiocephalic Veins | 1 | 1993 | 5 | 0.010 |
Why?
|
Venous Insufficiency | 1 | 1993 | 5 | 0.010 |
Why?
|
Jugular Veins | 1 | 1993 | 29 | 0.010 |
Why?
|
Thumb | 1 | 1993 | 27 | 0.010 |
Why?
|
Magnetics | 1 | 1993 | 53 | 0.010 |
Why?
|
Preoperative Care | 1 | 1993 | 190 | 0.010 |
Why?
|
Aorta | 1 | 1992 | 113 | 0.010 |
Why?
|
Cardiomegaly | 1 | 1989 | 34 | 0.000 |
Why?
|
Systole | 1 | 1989 | 109 | 0.000 |
Why?
|
Diastole | 1 | 1989 | 92 | 0.000 |
Why?
|
Phentolamine | 1 | 1988 | 7 | 0.000 |
Why?
|
Penile Erection | 1 | 1988 | 7 | 0.000 |
Why?
|
Papaverine | 1 | 1988 | 7 | 0.000 |
Why?
|
Radioisotope Renography | 1 | 1987 | 4 | 0.000 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1987 | 11 | 0.000 |
Why?
|
Methods | 1 | 1987 | 40 | 0.000 |
Why?
|
Microspheres | 1 | 1987 | 56 | 0.000 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1987 | 6 | 0.000 |
Why?
|
Urine | 1 | 1987 | 45 | 0.000 |
Why?
|
Dogs | 1 | 1987 | 325 | 0.000 |
Why?
|
Marfan Syndrome | 1 | 1985 | 18 | 0.000 |
Why?
|
Dichlorphenamide | 1 | 1984 | 1 | 0.000 |
Why?
|
Acetazolamide | 1 | 1984 | 3 | 0.000 |
Why?
|
Arthritis | 1 | 1984 | 53 | 0.000 |
Why?
|
Drug Interactions | 1 | 1984 | 127 | 0.000 |
Why?
|
Glaucoma | 1 | 1984 | 59 | 0.000 |
Why?
|
Aspirin | 1 | 1984 | 171 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1984 | 464 | 0.000 |
Why?
|
Animals | 1 | 1987 | 20627 | 0.000 |
Why?
|